Literature DB >> 16307600

Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.

Kuei Y Tseng1, Lucila Kargieman, Sebastian Gacio, Luis A Riquelme, M Gustavo Murer.   

Abstract

Severe chronic dopamine (DA) depletion increases the proportion of neurons in the basal ganglia that fire rhythmic bursts of action potential (LFO units) synchronously with the cortical oscillations. Here we report on how different levels of mesencephalic DA denervation affect substantia nigra pars reticulata (SNpr) neuronal activity in the rat and its relationship to akinesia (stepping test). Chronic nigrostriatal lesion induced with 0 (control group), 4, 6 or 8 microg of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle resulted in a dose-dependent decrease of tyrosine hydroxylase positive (TH+) neurons in the SN and ventral tegmental area (VTA). Although 4 microg of 6-OHDA reduced the number of TH+ neurons in the SN by approximately 60%, both stepping test performance and SNpr neuronal activity remained indistinguishable from control animals. By contrast, animals that received 6 microg of 6-OHDA showed a marked reduction of TH+ cells in the SN ( approximately 75%) and VTA ( approximately 55%), a significant stepping test deficit and an increased proportion of LFO units. These changes were not dramatically enhanced with 8 microg 6-OHDA, a dose that induced an extensive DA lesion (> 95%) in the SN and approximately 70% reduction of DA neurons in the VTA. These results suggest a threshold level of DA denervation for both the appearance of motor deficits and LFO units. Thus, the presence of LFO activity in the SNpr is not related to a complete nigrostriatal DA neuron depletion (ultimate stage parkinsonism); instead, it may reflect a functional disruption of cortico-basal ganglia dynamics associated with clinically relevant stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307600     DOI: 10.1111/j.1460-9568.2005.04456.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  19 in total

1.  Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/probenecid model of Parkinson's disease.

Authors:  Annadurai Anandhan; Musthafa Mohamed Essa; Thamilarasan Manivasagam
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  Concurrent upregulation of postsynaptic L-type Ca(2+) channel function and protein kinase A signaling is required for the periadolescent facilitation of Ca(2+) plateau potentials and dopamine D1 receptor modulation in the prefrontal cortex.

Authors:  Li-Jun Heng; Julie A Markham; Xiu-Ti Hu; Kuei Y Tseng
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

4.  Parafascicular thalamic nucleus activity in a rat model of Parkinson's disease.

Authors:  Louise C Parr-Brownlie; Stacey L Poloskey; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

5.  Escin, a novel triterpene, mitigates chronic MPTP/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis.

Authors:  Govindasamy Pushpavathi Selvakumar; Thamilarasan Manivasagam; Karamkolly R Rekha; Richard L Jayaraj; Namasivayam Elangovan
Journal:  J Mol Neurosci       Date:  2014-05-02       Impact factor: 3.444

6.  Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.

Authors:  Irene Avila; Louise C Parr-Brownlie; Elena Brazhnik; Edward Castañeda; Debra A Bergstrom; Judith R Walters
Journal:  Exp Neurol       Date:  2009-12-04       Impact factor: 5.330

7.  Short- and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons.

Authors:  Sonja Seeger-Armbruster; Andreas von Ameln-Mayerhofer
Journal:  Exp Brain Res       Date:  2012-10-09       Impact factor: 1.972

8.  Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.

Authors:  Przemyslaw Nowak; Aleksandra Bortel; Joanna Dabrowska; Joanna Oswiecimska; Marzena Drosik; Adam Kwiecinski; Józef Opara; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

Review 9.  What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity.

Authors:  A Quiroga-Varela; J R Walters; E Brazhnik; C Marin; J A Obeso
Journal:  Neurobiol Dis       Date:  2013-05-30       Impact factor: 5.996

10.  Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics.

Authors:  Jonathan Chetrit; Bérangère Ballion; Steeve Laquitaine; Pauline Belujon; Stéphanie Morin; Anne Taupignon; Bernard Bioulac; Christian E Gross; Abdelhamid Benazzouz
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.